51
Views
3
CrossRef citations to date
0
Altmetric
Original Research

The sustained-release behavior and in vitro and in vivo transfection of pEGFP-loaded core-shell-structured chitosan-based composite particles

, , , , , , & show all
Pages 4965-4978 | Published online: 23 Oct 2014

References

  • Cavazzana-CalvoMHacein-BeySde Saint BasileGGene therapy of human severe combined immunodeficiency (SCID)-X1 diseaseScience2000288546666967210784449
  • FlotteTRCarterBJAdeno-associated virus vectors for gene therapyGene Ther1995263573627584109
  • GaoXHuangLCationic liposome-mediated gene transferGene Ther19952107107228750010
  • HerweijerHWolffJAProgress and prospects: naked DNA gene transfer and therapyGene Ther200310645345812621449
  • ZhangXXPrataCAMcIntoshTJBarthélémyPGrinstaffMWThe effect of charge-reversal amphiphile spacer composition on DNA and SiRNA deliveryBioconjug Chem201021598899320433165
  • SteinSOttMGSchultze-StrasserSGenomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous diseaseNat Med201016219820420098431
  • HosseinkhaniHHeWJChiangCHBiodegradable nanoparticles for gene therapy technologyJ Nanopart Res2013151794115
  • ItakaKKataokaKRecent development of nonviral gene delivery systems with virus-like structures and mechanismsEur J Pharm Biopharm200971347548318955136
  • AtkinsonHChalmersRDelivering the goods: viral and non-viral gene therapy systems and the inherent limits on cargo DNA and internal sequencesGenetica2010138548549820084428
  • JoossKChirmuleNImmunity to adenovirus and adeno-associated viral vectors: implications for gene therapyGene Ther2003101195596312756416
  • FischerAHacein-Bey-AbinaSLagresleCCarrigueACavazana-CalvoMGene therapy of severe combined immunodeficiency disease: proof of principle of efficiency and safety issues. Gene therapy, primary immunodeficiencies, retrovirus, lentivirus, genomeBull Acad Natl Med2005189577978516433450
  • BuschmannMDMerzoukiALavertuMThibaultMJeanMDarrasVChitosans for delivery of nucleic acidsAdv Drug Deliv Rev20136591234127023872012
  • XuZPWalkerTLLiuKLCooperHMLuGQBartlettPFLayered double hydroxide nanoparticles as cellular delivery vectors of supercoiled plasmid DNAInt J Nanomedicine20072216317417722544
  • GoodayGWPhysiology of microbial degradation of chitin and chitosanRatledgeCBiochemistry of Microbial DegradationHeidelbergSpringer1994279312
  • JayakumarRChennazhiKPMuzzarelliRAATamuraHNairSVSelvamuruganNChitosan conjugated DNA nanoparticles in gene therapyCarbohydr Polym201079118
  • RoyKMaoHQHuangSKLeongKWOral gene delivery with chitosan–DNA nanoparticles generates immunologic protection in a murine model of peanut allergyNat Med19995438739110202926
  • YangPTHoangLJiaWWSkarsgardEDIn utero gene delivery using chitosan-DNA nanoparticles in miceJ Surg Res2011171269169920850772
  • BhattaraiNGunnJZhangMChitosan-based hydrogels for controlled, localized drug deliveryAdv Drug Deliv Rev2010621839919799949
  • PeerDKarpJMHongSFarokhzadOCMargalitRLangerRNanocarriers as an emerging platform for cancer therapyNat Nanotechnol200721275176018654426
  • ShuXZZhuKJControlled drug release properties of ionically cross-linked chitosan beads: the influence of anion structureInt J Pharm20022331–221722511897426
  • WangJJZengZWXiaoRZRecent advances of chitosan nanoparticles as drug carriersInt J Nanomedicine2011676577421589644
  • DobrovolskaiaMAMcNeilSEImmunological properties of engineered nanomaterialsNat Nanotechnol20072846947818654343
  • YouJOLiuYCPengCAEfficient gene transfection using chitosan–alginate core-shell nanoparticlesInt J Nanomedicine20061217318017722533
  • KawamuraKOishiJKangJHIntracellular signal-responsive gene carrier for cell-specific gene expressionBiomacromolecules20056290891315762659
  • Bravo-OsunaIVauthierCFarabolliniAPalmieriGFPonchelGMucoadhesion mechanism of chitosan and thiolated chitosan-poly (isobutyl cyanoacrylate) core-shell nanoparticlesBiomaterials200728132233224317261330
  • LiuWGZhangXSunSJN-alkylated chitosan as a potential nonviral vector for gene transfectionBioconjug Chem200314478278912862431
  • RamosVMRodríguezNMRodríguezMSHerasAAgullóEModified chitosan carrying phosphonic and alkyl groupsCarbohydr Polym2003514425429
  • MartinovichGGCherenkevichSNSauerHIntracellular redox state: towards quantitative descriptionEur Biophys J200534793794216215752
  • LoretzBThalerMBernkop-SchnürchARole of sulfhydryl groups in transfection? A case study with chitosan-NAC nanoparticlesBioconjug Chem20071841028103517552491
  • SchmitzTBravo-OsunaIVauthierCPonchelGLoretzBBernkop-SchnürchADevelopment and in vitro evaluation of a thiomer-based nanoparticulate gene delivery systemBiomaterials200728352453116979757
  • YuWYZhaoYXingYLA preliminary study on the evaluation of a novel gene delivery vector-TACS in vitro and in vivo via co-expressing hVEGF and hBMP genes to repair critical-size rabbit bone defectsAfr J Pharm Pharmaco201265343351
  • DangJMSunDDShin-YaYSieberANKostuikJPLeongKWTemperature-responsive hydroxybutyl chitosan for the culture of mesenchymal stem cells and intervertebral disk cellsBiomaterials200627340641816115680
  • AtkinsonPJWiseAKFlynnBONayagamBARichardsonRTViability of long-term gene therapy in the cochleaScientific Reports20144473324751795
  • MarshallNJGoodwinCJHoltSJA critical assessment of the use of microculture tetrazolium assays to measure cell growth and functionGrowth Regul19955269847627094